These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31547111)

  • 1. Hydrogel-Mediated DOX⋅HCl/PTX Delivery System for Breast Cancer Therapy.
    Hyun H; Yoo YB; Kim SY; Ko HS; Chun HJ; Yang DH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study.
    Hyun H; Park MH; Lim W; Kim SY; Jo D; Jung JS; Jo G; Um S; Lee DW; Yang DH
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):874-882. PubMed ID: 29749265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery.
    Hyun H; Park MH; Jo G; Kim SY; Chun HJ; Yang DH
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30634553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
    J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy.
    Liu C; Guo X; Ruan C; Hu H; Jiang BP; Liang H; Shen XC
    Acta Biomater; 2019 Sep; 96():281-294. PubMed ID: 31319202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
    Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
    Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
    Liang Y; Dong C; Zhang J; Deng L; Dong A
    Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro.
    Liu J; Zhang L; Yang Z; Zhao X
    Int J Nanomedicine; 2011; 6():2143-53. PubMed ID: 22114478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable, Adhesive Albumin Nanoparticle-Incorporated Hydrogel for Sustained Localized Drug Delivery and Efficient Tumor Treatment.
    Wang T; Ding J; Chen Z; Zhang Z; Rong Y; Li G; He C; Chen X
    ACS Appl Mater Interfaces; 2024 Feb; 16(8):9868-9879. PubMed ID: 38349713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment in vitro and in vivo.
    Yoo Y; Yoon SJ; Kim SY; Lee DW; Um S; Hyun H; Hong SO; Yang DH
    Drug Deliv; 2018 Nov; 25(1):1664-1671. PubMed ID: 30183420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
    Yang H; Tang C; Yin C
    Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
    Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO
    Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic effect of paclitaxel with a natural polysaccharide carrier for local injection in breast cancer.
    Jang H; Zhi K; Wang J; Zhao H; Li B; Yang X
    Int J Biol Macromol; 2020 Apr; 148():163-172. PubMed ID: 31935404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.